Literature DB >> 33184120

Exploratory study of the effectiveness of nebulised saline in children with neurodisability.

Natalia Galaz Souza1, Andrew Bush1,2, Hui-Leng Tan1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33184120      PMCID： PMC7970020          DOI： 10.1183/13993003.01407-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  19 in total

1.  Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.

Authors:  Mirjam Stahl; Mark O Wielpütz; Isabell Ricklefs; Christian Dopfer; Sandra Barth; Anne Schlegtendal; Simon Y Graeber; Olaf Sommerburg; Gesa Diekmann; Johannes Hüsing; Cordula Koerner-Rettberg; Lutz Nährlich; Anna-Maria Dittrich; Matthias V Kopp; Marcus A Mall
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

2.  Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  Felix Ratjen; Stephanie D Davis; Sanja Stanojevic; Richard A Kronmal; Karen D Hinckley Stukovsky; Neal Jorgensen; Margaret Rosenfeld
Journal:  Lancet Respir Med       Date:  2019-06-06       Impact factor: 30.700

3.  The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.

Authors:  Caroline H H Nicolson; Robert G Stirling; Brigitte M Borg; Brenda M Button; John W Wilson; Anne E Holland
Journal:  Respir Med       Date:  2012-02-19       Impact factor: 3.415

4.  The in vitro effect of nebulised hypertonic saline on human bronchial epithelium.

Authors:  Jennifer L Goralski; Dan Wu; William R Thelin; Richard C Boucher; Brian Button
Journal:  Eur Respir J       Date:  2018-05-17       Impact factor: 16.671

Review 5.  Nebulised hypertonic saline solution for acute bronchiolitis in infants.

Authors:  Linjie Zhang; Raúl A Mendoza-Sassi; Claire Wainwright; Terry P Klassen
Journal:  Cochrane Database Syst Rev       Date:  2017-12-21

Review 6.  Respiratory medicines for children: current evidence, unlicensed use and research priorities.

Authors:  A R Smyth; A Barbato; N Beydon; H Bisgaard; K de Boeck; P Brand; A Bush; B Fauroux; J de Jongste; M Korppi; C O'Callaghan; M Pijnenburg; F Ratjen; K Southern; D Spencer; A Thomson; H Vyas; A Warris; P J Merkus
Journal:  Eur Respir J       Date:  2009-10-19       Impact factor: 16.671

7.  A rating of perceived exertion scale using facial expressions for conveying exercise intensity for children and young adults.

Authors:  Yi-Lang Chen; Wen-Ko Chiou; Yu-Tung Tzeng; Ching-Yu Lu; Shih-Chi Chen
Journal:  J Sci Med Sport       Date:  2016-06-01       Impact factor: 4.319

Review 8.  Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function.

Authors:  Emer P Reeves; Cormac McCarthy; Oliver J McElvaney; Maya Sakthi N Vijayan; Michelle M White; Danielle M Dunlea; Kerstin Pohl; Noreen Lacey; Noel G McElvaney
Journal:  World J Crit Care Med       Date:  2015-08-04

9.  Spontaneous Breathing Pattern as Respiratory Functional Outcome in Children with Spinal Muscular Atrophy (SMA).

Authors:  A LoMauro; A Aliverti; C Mastella; M T Arnoldi; P Banfi; G Baranello
Journal:  PLoS One       Date:  2016-11-07       Impact factor: 3.240

10.  Advances toward the elucidation of hypertonic saline effects on Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  Anne-Laure Michon; Estelle Jumas-Bilak; Raphaël Chiron; Brigitte Lamy; Hélène Marchandin
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.